Cargando…

Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center

PURPOSE: We aimed to evaluate the clinico-pathological characteristics and survival outcomes of patients with synchronous or metachronous breast cancer (BC) and ovarian cancer (OC). MATERIALS AND METHODS: Patients with synchronous or metachronous BC and OC were retrospectively identified at two larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tasca, Giulia, Dieci, Maria Vittoria, Baretta, Zora, Faggioni, Giovanni, Montagna, Marco, Nicoletto, Maria Ornella, Peccatori, Fedro Alessandro, Guarneri, Valentina, Colombo, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768039/ https://www.ncbi.nlm.nih.gov/pubmed/33381461 http://dx.doi.org/10.3389/fonc.2020.608783

Ejemplares similares

Trabectedin plus Pegylated Liposomal Doxorubicin: Retrospective Analysis in Heavily Pretreated Platinum-sensitive Ovarian Cancer
por: Nicoletto, Maria Ornella, et al.
Publicado: (2015)

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer
por: Cont, Nicoletta Tomasi, et al.
Publicado: (2015)

Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications
por: Dieci, Maria Vittoria, et al.
Publicado: (2021)

Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
por: Gadducci, Angiolo, et al.
Publicado: (2019)

Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study
por: Mosconi, Paola, et al.
Publicado: (2022)

Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
por: Miglietta, Federica, et al.
Publicado: (2019)

Immune characterization of breast cancer metastases: prognostic implications
por: Dieci, Maria Vittoria, et al.
Publicado: (2018)

An overview of immune checkpoint inhibitors in breast cancer
por: Miglietta, Federica, et al.
Publicado: (2020)

Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer
por: Massa, Davide, et al.
Publicado: (2022)

Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
por: Griguolo, Gaia, et al.
Publicado: (2019)

Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation
por: Serio, Gabriella, et al.
Publicado: (2022)

Isolated metachronous splenic metastasis from synchronous colon cancer
por: Gencosmanoglu, Rasim, et al.
Publicado: (2006)

Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective
por: Guzzinati, Stefano, et al.
Publicado: (2023)

Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
por: Fumagalli, Caterina, et al.
Publicado: (2019)

Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
por: Lee, Janghee, et al.
Publicado: (2015)

Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases
por: Suh, Byoung Jo
Publicado: (2016)

Metachronous or synchronous male breast and prostate cancers a duality to lookout for.
por: Mukendi, Alain Mwamba, et al.
Publicado: (2019)

Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers
por: Jeong, Shinseok, et al.
Publicado: (2017)

Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer
por: Shibukawa, Narihiro, et al.
Publicado: (2017)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer
por: Bartolini, Ilenia, et al.
Publicado: (2018)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review
por: Anderson, Richard A, et al.
Publicado: (2022)

Chemotherapy and anti-HER2 therapy in metastatic breast cancer in pregnancy followed by surgical treatment
por: Berwart, Julia, et al.
Publicado: (2019)

Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases
por: Di Liso, Elisabetta, et al.
Publicado: (2020)

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
por: Dieci, Maria Vittoria, et al.
Publicado: (2021)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

An Unusual Occurrence of Multiple Metachronous and Synchronous Primary Cancers in a Female Patient
por: Torina, Tyler B., et al.
Publicado: (2020)

Synchronous and metachronous thyroid cancer, breast cancer, and melanoma in a premenopausal patient with Cowden syndrome
por: Asare, Belinda, et al.
Publicado: (2023)

Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?
por: Moschovi, Maria, et al.
Publicado: (2015)

Glufosinate constrains synchronous and metachronous metastasis by promoting anti‐tumor macrophages
por: Menga, Alessio, et al.
Publicado: (2020)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites
por: Kim, Joo Hoon, et al.
Publicado: (2010)

Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer
por: Zhang, Li, et al.
Publicado: (2016)

Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
por: Kim, Kyu-pyo, et al.
Publicado: (2017)

Two rare cases of synchronous and metachronous colonic metastases in patients with advanced gastric cancer
por: Su, Wei-Chih, et al.
Publicado: (2018)

Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer
por: Ding, Shuning, et al.
Publicado: (2021)

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
por: Yun, Sumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cr9egieo5j558jltjdjpt182sd